Clinical studies recruiting near Davis

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390 Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
Phase 2 · Montefiore Medical Center · NCT05184842 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Pfizer · NCT07073820 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With
Phase 1/Phase 2 · Hoffmann-La Roche · NCT05987449 Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · Ad scientiam · NCT05566769 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Takeda · NCT07108283 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478 A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · Clasp Therapeutics, Inc. · NCT06778863 Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT04172532 Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment
NA · University of California, Davis · NCT07024498 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · National Cancer Institute (NCI) · NCT06860594 Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Can
Phase 2 · National Cancer Institute (NCI) · NCT05691465 Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
Phase 1/Phase 2 · EicOsis Human Health Inc. · NCT07142044 Prospective Evaluation of Topical Almond Oil vs Hydroquinone
Phase 4 · University of California, Davis · NCT04875715 LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
NA · University of California, Davis · NCT06103682 Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events
NA · University of California, Davis · NCT06114615 Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Interventio
NA · University of California, Davis · NCT06574178 Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Phase 4 · University of California, Irvine · NCT05586776 Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Chang
Phase 1 · National Cancer Institute (NCI) · NCT05372614 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Eli Lilly and Company · NCT07222332 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Regeneron Pharmaceuticals · NCT06091865 Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
NA · University of California, Davis · NCT06103669 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Oncology Group · NCT04322318 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · UroGen Pharma Ltd. · NCT06774131 Alternation in the Human Microbiome With Commonly Used Topical Medications
Phase 1 · University of California, Davis · NCT03437005

Look up another city

Look up another condition